NASDAQ:LUCD

Lucid Diagnostics Stock Insider Trading

etoro logo Buy LUCD
*Your capital is at risk
$1.01
-0.0250 (-2.43%)
At Close: Jun 03, 2026

Lucid Diagnostics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 22.4M and sold 6.74M LUCD shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 22.4M shares
Sell 6.74M shares
76% Buy Activity
Strong Positive Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Feb 20, 2025
Buy
Common Stock
A-Award
White Debra
Director
Director 112 800
Value: $168.1K
Feb 20, 2025
Buy
Common stock
A-Award
Sparks Ronald M
Director
Director 112 800
Value: $168.1K
May 08, 2024
Buy
Employee stock option (right to buy)
A-Award
Matheis Dennis
Director
Director 241 500
Value: $248.7K
May 08, 2024
Buy
Employee stock option (right to buy)
A-Award
Matheis Dennis
Director
Director 241 500
Value: $248.7K
May 07, 2024
Buy
Common stock
A-Award
Gordon Michael Adam
General Counsel And Secretary
Officer 400 000
Value: $0
May 07, 2024
Buy
Common stock
A-Award
O'neil Shaun
President And COO
CEO / President 400 000
Value: $0
May 07, 2024
Buy
Common stock
A-Award
Mcgrath Dennis M
Chief Financial Officer
C-Suite Officer 400 000
Value: $0
May 07, 2024
Buy
Common stock
A-Award
Aklog Lishan
Chief Executive Officer
CEO / President 400 000
Value: $0
May 07, 2024
Buy
Common stock
A-Award
Gordon Michael Adam
General Counsel And Secretary
Officer 400 000
Value: $0
May 07, 2024
Buy
Common stock
A-Award
O'neil Shaun
President And COO
CEO / President 400 000
Value: $0
May 07, 2024
Buy
Common stock
A-Award
Mcgrath Dennis M
Chief Financial Officer
C-Suite Officer 400 000
Value: $0
May 07, 2024
Buy
Common stock
A-Award
Aklog Lishan
Chief Executive Officer
CEO / President 400 000
Value: $0
May 06, 2024
Buy
Common stock
Matheis Dennis
Director
Director 0
Value: $0
May 06, 2024
Buy
Common stock
Matheis Dennis
Director
Director 0
Value: $0
Feb 22, 2024
Buy
Employee stock option (right to buy)
A-Award
White Debra
Director
Director 150 000
Value: $184.5K
Feb 22, 2024
Buy
Employee stock option (right to buy)
A-Award
Sparks Ronald M
Director
Director 150 000
Value: $184.5K
Feb 22, 2024
Buy
Employee stock option (right to buy)
A-Award
Lapidus Stanley
Director
Director 150 000
Value: $184.5K
Feb 22, 2024
Buy
Employee stock option (right to buy)
A-Award
Cox James L
Director
Director 150 000
Value: $184.5K
Feb 22, 2024
Buy
Employee stock option (right to buy)
A-Award
Sokolov Jacque J
Director
Director 150 000
Value: $184.5K
Feb 22, 2024
Buy
Employee stock option (right to buy)
A-Award
White Debra
Director
Director 150 000
Value: $184.5K
Feb 22, 2024
Buy
Employee stock option (right to buy)
A-Award
Sparks Ronald M
Director
Director 150 000
Value: $184.5K
Feb 22, 2024
Buy
Employee stock option (right to buy)
A-Award
Lapidus Stanley
Director
Director 150 000
Value: $184.5K
Feb 22, 2024
Buy
Employee stock option (right to buy)
A-Award
Cox James L
Director
Director 150 000
Value: $184.5K
Feb 22, 2024
Buy
Employee stock option (right to buy)
A-Award
Sokolov Jacque J
Director
Director 150 000
Value: $184.5K
Feb 15, 2024
Sell
Common Stock
J-Other
Pavmed Inc.
10 Percent Owner
10% Owner 3 331 747
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT LUCID DIAGNOSTICS INC.
Lucid Diagnostics
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its lead products include EsoGuard, a laboratory developed esophageal DNA test; and EsoCheck, an...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE